ALNY
Price
$401.80
Change
+$62.00 (+18.25%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
52.67B
83 days until earnings call
ATHA
Price
$0.37
Change
-$0.01 (-2.63%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
14.45M
17 days until earnings call
Interact to see
Advertisement

ALNY vs ATHA

Header iconALNY vs ATHA Comparison
Open Charts ALNY vs ATHABanner chart's image
Alnylam Pharmaceuticals
Price$401.80
Change+$62.00 (+18.25%)
Volume$21.71K
Capitalization52.67B
Athira Pharma
Price$0.37
Change-$0.01 (-2.63%)
VolumeN/A
Capitalization14.45M
ALNY vs ATHA Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. ATHA commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and ATHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ALNY: $391.99 vs. ATHA: $0.38)
Brand notoriety: ALNY and ATHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 342% vs. ATHA: 17%
Market capitalization -- ALNY: $52.67B vs. ATHA: $14.84M
ALNY [@Biotechnology] is valued at $52.67B. ATHA’s [@Biotechnology] market capitalization is $14.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileATHA’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ATHA’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ATHA’s TA Score has 3 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • ATHA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than ATHA.

Price Growth

ALNY (@Biotechnology) experienced а +19.51% price change this week, while ATHA (@Biotechnology) price change was -17.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

ATHA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($52.7B) has a higher market cap than ATHA($14.5M). ALNY YTD gains are higher at: 66.585 vs. ATHA (-35.231). ATHA has higher annual earnings (EBITDA): -77.65M vs. ALNY (-152.58M). ALNY has more cash in the bank: 2.63B vs. ATHA (36.7M). ATHA has less debt than ALNY: ATHA (1.12M) vs ALNY (1.3B). ALNY has higher revenues than ATHA: ALNY (2.35B) vs ATHA (0).
ALNYATHAALNY / ATHA
Capitalization52.7B14.5M363,448%
EBITDA-152.58M-77.65M196%
Gain YTD66.585-35.231-189%
P/E RatioN/AN/A-
Revenue2.35B0-
Total Cash2.63B36.7M7,172%
Total Debt1.3B1.12M116,562%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYATHA
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
65%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGI4.500.55
+13.92%
FGI Industries Ltd
ATHM27.090.07
+0.26%
Autohome
PEBK28.62-0.12
-0.42%
Peoples Bancorp of North Carolina
CLS199.86-2.55
-1.26%
Celestica
CHGG1.31-0.04
-2.96%
CHEGG

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+6.44%
OGEN - ATHA
38%
Loosely correlated
-2.33%
ALNY - ATHA
35%
Loosely correlated
+15.36%
PCVX - ATHA
33%
Poorly correlated
-2.50%
PBM - ATHA
32%
Poorly correlated
-6.16%
MNKD - ATHA
32%
Poorly correlated
-2.45%
More